What is the appropriate management plan for a patient with respiratory failure?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

SOAP Note for Patient with Respiratory Failure

Subjective

  • Chief complaint: Document degree of dyspnea, ability to speak in full sentences, and duration of symptoms 1
  • Symptom severity: Assess work of breathing by asking about use of accessory muscles and ability to complete activities 2
  • Past medical history: Specifically inquire about COPD, asthma, neuromuscular disease, chest wall deformity, heart failure, or obstructive sleep apnea 3
  • Smoking history and recent infections: Critical for determining etiology and prognosis 4
  • Goals of care: Document patient wishes regarding intubation and invasive mechanical ventilation at presentation 3

Objective

  • Vital signs: Respiratory rate (concerning if >30/min), heart rate, blood pressure, oxygen saturation, mental status 1, 2
  • Physical examination:
    • Work of breathing: accessory muscle use, paradoxical breathing, ability to speak
    • Auscultation: wheezing, crackles, diminished breath sounds
    • Cardiovascular: signs of fluid overload or shock
    • Neurological: level of consciousness (drowsiness/confusion indicates impending failure) 2
  • Arterial blood gas (ABG): Mandatory before initiating treatment to classify Type I (hypoxemic: PaO₂ <60 mmHg with normal/low PaCO₂) versus Type II (hypercapnic: PaCO₂ >45 mmHg with respiratory acidosis) 1, 2
  • Chest X-ray: Obtain to identify pneumonia, pulmonary edema, pneumothorax, but do not delay treatment in severe cases 1, 4
  • ECG: Rule out ST-elevation myocardial infarction and assess for arrhythmias 3

Assessment

Type of respiratory failure (based on ABG):

  • Type I (Hypoxemic): PaO₂ <60 mmHg with normal or low PaCO₂ 2
  • Type II (Hypercapnic): PaCO₂ >45 mmHg with pH <7.35 3

Severity classification for hypercapnic failure:

  • pH 7.30-7.35: Moderate acidosis - manage on respiratory ward with specialist support 3
  • pH 7.25-7.30: Severe acidosis - requires HDU/ICU level care 3
  • pH <7.25: Critical acidosis - requires ICU with immediate intubation capability 3

Underlying etiology: COPD exacerbation, pneumonia, cardiogenic pulmonary edema, ARDS, neuromuscular disease, etc. 4

Plan

Immediate Management (First 30 minutes)

For Type II (Hypercapnic) Respiratory Failure:

  1. Controlled oxygen therapy: Target SpO₂ 88-92% immediately using Venturi mask or nasal cannula 3, 1

    • Recheck ABG after 1-2 hours to ensure adequate oxygenation without worsening hypercapnia 1, 4
  2. Optimal medical therapy (before considering NIV):

    • Nebulized bronchodilators: Albuterol 2.5 mg via nebulizer every 4-6 hours 4, 5
    • Systemic corticosteroids: Prednisolone 30-40 mg daily for COPD exacerbations 4
    • Antibiotics if indicated: For purulent sputum or requiring mechanical ventilation (5-7 day course) 4
  3. Non-invasive ventilation (NIV): Initiate when pH <7.35 and PaCO₂ >6.5 kPa persist despite optimal medical therapy 3, 1

    • Start with IPAP 10-12 cmH₂O, EPAP 4-5 cmH₂O, gradually increase as tolerated 1
    • Use full-face mask initially for better seal 3, 1
    • Maximize NIV hours in first 24 hours (aim for near-continuous use with breaks for meals/medications) 1, 4
    • Recheck ABG at 1-2 hours, then 4-6 hours if initial improvement minimal 1, 4
    • If pH and PaCO₂ worsen or fail to improve after 4-6 hours on optimal NIV settings, proceed to invasive mechanical ventilation 1

For Type I (Hypoxemic) Respiratory Failure:

  1. High-flow nasal oxygen (HFNO): Preferred initial therapy at 40-60 L/min targeting SpO₂ 94-98% 2, 6

    • Superior to conventional oxygen therapy for reducing mortality (ARD -15.8%) 2
    • Better tolerated than NIV in pure hypoxemic failure 2
  2. Escalation if HFNO fails (SpO₂ <90% despite HFNO):

    • Consider NIV with CPAP/BiPAP, particularly for cardiogenic pulmonary edema 2
    • Prepare for invasive mechanical ventilation if non-invasive support fails 2

Location of Care

  • pH >7.30: Respiratory ward with trained NIV staff and clear escalation protocols 3
  • pH 7.25-7.30: HDU or ICU 3
  • pH <7.25 or severe hypoxemia (PaO₂/FiO₂ <100): ICU with immediate intubation capability 3, 2

Monitoring

  • Continuous pulse oximetry for at least 24 hours 1, 4
  • Serial ABGs: At 1-2 hours after any intervention, then every 4-6 hours until stable 1, 4
  • Clinical parameters every 1-2 hours: Respiratory rate, heart rate, blood pressure, mental status, work of breathing 1
  • ROX index (SpO₂/FiO₂ ÷ respiratory rate) if using HFNO: >4.88 at 2 hours predicts success; <3.85 at 12 hours predicts failure 6

Invasive Mechanical Ventilation Criteria

Proceed to intubation when:

  • NIV failure: worsening pH/PaCO₂ after 4-6 hours despite optimal settings 1
  • Cardiovascular instability or shock 7
  • Severely impaired mental status or inability to protect airway 7
  • Respiratory arrest imminent or apnea 7
  • Contraindications to NIV: severe facial trauma, fixed upper airway obstruction, inability to clear secretions 3

Ventilator settings for invasive ventilation:

  • Tidal volume 6 mL/kg ideal body weight 1, 2
  • Plateau pressure <30 cmH₂O 1, 2
  • Appropriate PEEP based on oxygenation needs 1

Documentation Requirements

  • Individualized treatment plan at initiation including specific escalation criteria and intubation thresholds 1, 2
  • Code status and goals of care discussion documented, particularly regarding invasive ventilation 3
  • Consultation with ICU if pH <7.30 or high risk of NIV failure 3

Disposition Planning

  • Before discharge: Check ABG on room air, perform spirometry if COPD, arrange early follow-up <30 days 4
  • Referrals: Consider home NIV service for neuromuscular disease, chest wall deformity, or morbid obesity with recurrent hypercapnic failure 1
  • Patient education: Provide warning card regarding controlled oxygen therapy for future presentations 3

Common Pitfalls to Avoid

  • Do not delay NIV while waiting for chest X-ray in severe acidosis 3
  • Do not use excessive oxygen - hypercapnic patients require controlled oxygen at 88-92% saturation 3
  • Do not persist with failing NIV - worsening pH/respiratory rate after 4-6 hours mandates escalation 1
  • Do not use NIV in acute asthma exacerbations - proceed directly to invasive ventilation if needed 3
  • Severe acidosis (pH <7.25) does not preclude NIV trial but requires ICU setting with immediate intubation capability 3

References

Guideline

Management of Acute Respiratory Failure

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Type 1 Respiratory Failure

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Respiratory Failure

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.